A protein called Runx2 contributes to the abnormal activity of lung cells that drive pulmonary fibrosis, a new study shows.

Columnist Ann Reynoso, who's now preparing for a bilateral lung transplant, is counting on her strength and perseverance to ...

As snow falls at his home, columnist Sam Kirton remembers how he's had to accept limitations, especially since his bilateral ...

Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase ...

Low total cholesterol levels were tied to an increased risk of death for pulmonary fibrosis patients with disease of unknown ...

Charlene Marshall is a fiercely independent 30-something-year-old who can’t sit still. She loves coffee, wine tasting, playing with her dog, and spending time on the beach with her family. She’s a ...

Mediar Therapeutics is planning to launch a Phase 2 clinical trial to test its experimental therapy MTX-463 in people with idiopathic pulmonary fibrosis (IPF). The company has entered into a global ...

Sam Kirton started his column in November 2021 and writes from his home at Lake Anna, Virginia, where he lives with his wife Susan. His diagnosis at age 59 with idiopathic pulmonary fibrosis in ...

We’re not all the same. When I share details about my journey with idiopathic pulmonary fibrosis (IPF), I don’t want to give the impression that I’m setting a standard. My goal in writing this column ...